-The Hindu The State Information Commission agreed to consider some of the demands of the RTI Kerala Federation and other organisations that staged a dharna before the commission here on Tuesday. In talks with leaders of the organisations, Chief Information Commissioner Siby Mathews said the commission would consider their representation against delegation of its powers regarding disposal of petitions to officials. The commission had been returning complaints recently, on grounds that first appeals...
More »SEARCH RESULT
AIDAN proposes another pricing model for essential drugs by Khomba Singh
A non-government organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix retail prices at the average price of all brands in a segment. The proposal of the All India Drug Action Network (AIDAN) is being examined by the department of pharmaceuticals (DoP), an official said. AIDAN says its new pricing mechanism, which excludes brands that account for the top 20% by sales, will make...
More »White paper on black money likely in Budget Session: Govt
-PTI The Government today said it is likely to table a White Paper on black money during the ongoing Budget Session of Parliament, but maintained that there is no authentic estimate of the quantum of illicit wealth. "The white paper is likely to be brought during the Budget Session," Minister of State for Finance S S Palanimanickam informed the Rajya Sabha in a written reply. The White Paper is expected to contain information...
More »Gujarat 2002 and Modi’s Misdeeds by Anand Teltumbde
Ten years after the killings in Gujarat, Narendra Modi has neither expressed regret nor has he been held accountable for those mass deaths. Where do we go from here? Anand Teltumbde (tanandraj@gmail.com) is a writer and civil rights activist with the Committee for the Protection of Democratic Rights, Mumbai. Just thinking of it, a shiver runs down my spine. I had my own brush with how the Hindutva gangs carried out the...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »